Patents Assigned to UNIOGEN OY
  • Patent number: 12435365
    Abstract: Disclosed are novel lanthanide(III) chelates including a pyridine 4-ethynylpyrazine subunit. These chelates have an excitation wavelength which allows excitation with UV LED.
    Type: Grant
    Filed: November 3, 2020
    Date of Patent: October 7, 2025
    Assignee: UNIOGEN OY
    Inventor: Qi Wang
  • Publication number: 20250102510
    Abstract: The present disclosure relates to non-invasive diagnostics of cancers, especially breast cancer, colorectal cancer, pancreatic cancer and prostate cancer, on the basis of altered glycosylation patterns of cancer-associated biomarkers.
    Type: Application
    Filed: December 6, 2024
    Publication date: March 27, 2025
    Applicant: UNIOGEN OY
    Inventors: Kamlesh GIDWANI, Kim PETTERSSON, Henna KEKKI
  • Patent number: 12228743
    Abstract: A reader device for detecting a test result from a testing element carrying a sample includes a radiation source for emitting electromagnetic radiation, an optical system for directing the electromagnetic radiation to the testing element, and a detector for receiving electromagnetic radiation from the testing element and for producing a detection signal responsive to the received electromagnetic radiation. The optical system includes a guide rod for conducting electromagnetic radiation and a lens system for focusing the electromagnetic radiation coming out via an egress-end surface of the guide rod to the testing element. The egress end-surface of the guide rod has an elongated shape so that a radiation pattern having an elongated shape is produced on the testing element. The elongated shape of the radiation pattern facilitates scanning the testing element with the electromagnetic radiation.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: February 18, 2025
    Assignee: UNIOGEN OY
    Inventor: Pauli Salmelainen
  • Patent number: 12196756
    Abstract: The present disclosure relates to non-invasive diagnostics of cancers, such as breast cancer, colorectal cancer, pancreatic cancer and prostate cancer, on the basis of altered glycosylation patterns of cancer-associated biomarkers.
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: January 14, 2025
    Assignee: UNIOGEN OY
    Inventors: Kamlesh Gidwani, Kim Pettersson, Henna Kekki